May 9, 2022NuvOx Appoints Dr. Robert King to SABTucson, AZ, May 9th, 2022 – https://www.pr.com/press-release/861001 NuvOx Pharma, a clinical stage biotechnology company developing a...
May 9, 2022NuvOx Technology Featured in Prominent Peer Review JournalTucson, AZ, April 19, 2022 -- https://www.pr.com/press-release/859633 NuvOx Pharma’s technology, which is developed as a first-in-class...
May 9, 2022NuvOx Finalizes Facility Certification, Poising for Phase IIb TrialsTucson, AZ, April 17, 2022 -- https://www.pr.com/press-release/859467 NuvOx Pharma, a clinical stage biotechnology company developing a...
Mar 4, 2022NuvOx Receives Notice from the Breakthrough DOD Award for its Immuno-Oncology ProgramOn February 11th, 2022,-- https://www.pr.com/press-release/859467 NuvOx Pharma received notice from the Department of Defense (DOD)...
Feb 9, 2022NuvOx to Participate in the BIO CEO Investor ConferenceTucson, AZ, February 10, 2022 – NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat...